ST. LOUIS — Researchers at Saint Louis University are part of a study looking at an oral drug aimed at helping people with multiple sclerosis.
Saint Louis University researchers study oral drug for multiple sclerosis
To read the full article, please sign up or login.
Get full access to the Columbia Missourian on your computer, phone, and tablet for just $5.95 per month.
* All the high-quality, in-depth journalism of the Columbia Missourian and Vox Magazine, updated 24/7
* Your news. Your device. Your time.
If you'd like to read more about the value of being a member, read this column from the Missourian's executive editor, Tom Warhover.